Key areas of focus include:

As the field of regenerative medicine and Cell Therapies advances, it underscores a longstanding imperative: the quality, safety, and efficacy of these products has always been and remains the most crucial aspect of any therapy.

While a multi-faceted approach to quality is a standard across various therapies, Cell Therapies present unique challenges due to their nature as living therapies. Specifications for these products will inherently exhibit a range because they are derived from living cells. Consequently, testing strategies for Cell Therapies are more risk-based and require a tailored approach when compared to non-Advanced Therapy Medicinal Products (non-ATMPs).

• Understanding Cell Therapies
• The Importance of Product Quality
• Building a Quality Strategy
• Testing and Validation
• Regulatory Landscape
  

Our experts can provide insights and answer your queries to advance your cell therapy development. This webinar is designed to help you explore and navigate the complexities of product quality strategies for cell therapies. If you have additional questions, we invite you to share them.

Key areas of focus include:

• Transitioning from Bench to GMP Suitable Processes
• Identifying Technologies for Scale-Up and Future Manufacturing
• New GMP iPSC Generation
• Master and Working Cell Bank Creation
• Quality Control Strategies for Safe Products

Our experts can provide insights and answer your queries to advance your therapy development. This webinar is designed to help you explore and navigate the complexities of iPSC therapy development, but if you have additional questions, we invite you to ask us your questions.